Cronos Group Inc Asset Resilience Ratio
Cronos Group Inc asset resilience ratio. Cronos Group Inc (CRON) has an Asset Resilience Ratio of 69.94% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Cronos Group Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Cronos Group Inc (2016–2024)
Asset resilience ratio of Cronos Group Inc from 2016 to 2024. This chart shows how Cronos Group Inc's Asset Resilience Ratio has changed over time. Read how much debt does Cronos Group Inc carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Cronos Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CRON asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$784.17 Million | 66.54% |
| Short-term Investments | CA$40.00 Million | 3.39% |
| Total Liquid Assets | CA$824.17 Million | 69.94% |
Asset Resilience Insights
- Very High Liquidity: Cronos Group Inc maintains exceptional liquid asset reserves at 69.94% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Cronos Group Inc Industry Peers by Asset Resilience Ratio
Compare Cronos Group Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Cronos Group Inc Asset Resilience Ratio by Year (2016–2024)
Cronos Group Inc asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Cronos Group Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 73.63% | CA$858.80 Million ≈ $621.25 Million |
CA$1.17 Billion ≈ $843.69 Million |
-1.93pp |
| 2023-12-31 | 75.57% | CA$861.53 Million ≈ $623.22 Million |
CA$1.14 Billion ≈ $824.72 Million |
+3.21pp |
| 2022-12-31 | 72.36% | CA$877.72 Million ≈ $634.93 Million |
CA$1.21 Billion ≈ $877.47 Million |
+0.48pp |
| 2021-12-31 | 71.88% | CA$1.00 Billion ≈ $726.75 Million |
CA$1.40 Billion ≈ $1.01 Billion |
+4.90pp |
| 2020-12-31 | 66.98% | CA$1.29 Billion ≈ $933.01 Million |
CA$1.93 Billion ≈ $1.39 Billion |
-5.07pp |
| 2019-12-31 | 72.04% | CA$1.51 Billion ≈ $1.09 Billion |
CA$2.09 Billion ≈ $1.51 Billion |
+59.56pp |
| 2018-12-31 | 12.48% | CA$23.93 Million ≈ $17.31 Million |
CA$191.71 Million ≈ $138.68 Million |
+3.78pp |
| 2017-12-31 | 8.70% | CA$6.99 Million ≈ $5.06 Million |
CA$80.34 Million ≈ $58.12 Million |
+0.46pp |
| 2016-12-31 | 8.24% | CA$2.63 Million ≈ $1.90 Million |
CA$31.92 Million ≈ $23.09 Million |
-- |
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.